Enhanced Everolimus Delivery: Development and Evaluation of a Nanosuspension Formulation
Qiao Zeng, Jie Chen, Han Zhang, Wenying Yu, Haonan Xu, Qiao Wang, Zhan Tang · 2025
Read Enhanced Everolimus Delivery: Development and Evaluation of a Nanosuspension Formulation by Qiao Zeng, Jie Chen, Han Zhang, Wenying Yu, Haonan Xu, Qiao Wang, Zhan Tang (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12766126.txt.
Description
Zeng and co-authors present a 2025 study on a nano-form of everolimus for treating unwanted blood vessels in the cornea. Corneal vessel growth clouds vision, and the drug everolimus can curb it if delivered well. The team loaded the drug into a nanosuspension with particles near one hundred forty nanometers wide. Cell tests tracked how eye surface cells took the particles in.
Uptake rose with time and used several entry routes into the cells. The formula blocked vessel cell growth, movement, and tube building in dishes. In a rabbit eye model it shrank new vessels and quieted inflammation genes. Irritation tests showed the drops were gentle. The authors back it for further study.
Catalog record
| CREATOR | Qiao Zeng, Jie Chen, Han Zhang, Wenying Yu, Haonan Xu, Qiao Wang, Zhan Tang |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |